THE shortage of Ozempic (semaglutide) has been extended to 31 Dec.
To help patients continue their treatment without interruption, the TGA recommended it only be used for the registered indications.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Sep 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Sep 23
